Our Partnerships and Contributions in the UK

Ipsen in partnership

At Ipsen, we strive to be a creative and like-minded partner of choice. We believe that achieving the best results for patients depends on our ability to work effectively and ethically in partnership with those around us, including healthcare professionals, the NHS and HSE, patient groups, policy makers and government. 

Ipsen understands that working in partnership with those around us is a cornerstone of achieving meaningful change for patients. As a growing organisation with a dynamic and agile mindset, we are continuously trying to identify ways in which Ipsen can support the UK and Ireland healthcare ecosystem. It is our aim to meet both the needs of patients and the community who care for them.

Whether working with world-leading scientists investigating cutting-edge neuroscience, partnering with the NHS and HSE to improve care for patients, or working with patient groups on disease awareness initiatives, we strive to establish partnerships with strong ethical foundations and bold ambitions.

Our contribution

Ipsen invests significantly in the UK as part of our ongoing commitment to driving positive change for patients, supporting the NHS, and offering exceptional people a great place to work. We have successfully brought eight new treatments or indications to the UK market in recent years. Our bold ambition is to launch at least one new product or meaningful indication each year.

Every year, we invest millions into the British economy, generating meaningful impact to society. From 2019 to October 2021 Ipsen invested around £86.8m into our UK & Ireland sites, developing facilities as well as our clinical and R&D programmes.

Supporting future talent

Ipsen has a long-standing commitment to promoting careers in science and STEM, and has a variety of graduate and apprenticeship schemes open to young people with a passion for science.  Ipsen is looking across its UK and Ireland business to ensure career opportunities are equal to people from all backgrounds.

Ipsen’s first graduate programme began in October 2018 from our Wrexham site.  Two graduates began our 24-month training programme, supporting the Manufacturing Technical and Quality Aseptic functions. Our graduates benefitted from the full insight into both the manufacturing and quality processes at our site.

Additionally, in September 2020 the Bath Road site in Slough has welcomed 3 graduates onto the Specialty Care Graduate Development Programme. The 18 months spent with Ipsen enables them to rotate into 3 departments for 6 months at a time, gaining insights into functions such as Business and Customer Excellence, Corporate Affairs, Medical Affairs, Finance and Marketing.

In 2017, Ipsen Biopharm was nominated as one of only three finalists at the UK STEM (Science, Technology, Engineering and Mathematics) Inspiration awards in the ‘Employer – Large Companies’ category.

More recently, July 2021, Ipsen launched ‘The Future of Science’ survey with New Scientist, targeting young people (aged 7-21 years old) to understand their current perceptions of careers in science. The survey revealed that 41% of the young people said the pandemic had increased their interest in science and medical careers, with 83% of respondents believing they would consider a career into these areas.

Key highlights from the survey include:

  • 2 in 5 young people felt science and medicine related jobs are not equally accessible to people from all ethnic backgrounds and genders, with this belief increasing with age and rising to 51% of the 16–21-year-old sub-population.
  • 35% of 16- to 21-year-olds said they have not had a conversation about university courses or career options in medical and life sciences at school.

17% of young people were put off a career in science because they don’t trust the pharmaceutical industry.

John Chaddock, VP Head of REED Operations at Ipsen and Site Head Ipsen Milton Park, comments: “Whilst it is encouraging to learn that the COVID-19 pandemic has prompted more young people to consider a career in science, it is worrying that gender and ethnicity present potential barriers. It is imperative we heed the issues highlighted by this research and work collectively with peers in both government and the life sciences industry to address them in order to ensure the UK remains at the cutting edge of scientific research.”

Future of science study – survey highlights.

Watch below Future of Science advertorial

Our Collaborations


January 2022

© Ipsen Group 2022